Beste Hämatologe-Onkologen - TOP-339 Ärzte

Der Inhalt entspricht den Redaktionsrichtlinien von Bookimed und wurde auf Qualität geprüft
Fahad Mawlood - Allgemeinarzt. Gewinner von 4 wissenschaftlichen Preisen. Er diente in Westasien. Ehemaliger Teamleiter eines medizinischen Teams zur Betreuung arabischsprachiger Patienten. Jetzt Fahad ist verantwortlich für die Datenverarbeitung und die Genauigkeit der medizinischen Inhalte.
Jorg Groticke
Klinischer Onkologe/-in
4.2
37 Rezensionen
Deutschland, Bremen
Krankenhaus Bremen Mitte (Bremen-Mitte Clinic)

Jorg Groticke

Klinischer Onkologe/-in

Professor Jörg Groticke ist Chefarzt des Zentrums für Onkologie und Hämatologie am Klinikum Bremen Mitte mit den Schwerpunkten Behandlung von hämatologischen Malignomen und Magen-Darm-Tumoren. Er ist Mitglied mehrerer medizinischer Organisationen und bietet Fernkonsultationen für Zweitmeinungen an.

Mehr lesen

Professor Jörg Groticke ist Chefarzt des Zentrums für Onkologie und Hämatologie am Klinikum Bremen Mitte mit den Schwerpunkten Behandlung von hämatologischen Malignomen und Magen-Darm-Tumoren. Er ist Mitglied mehrerer medizinischer Organisationen und bietet Fernkonsultationen für Zweitmeinungen an.

Mehr lesen
Doctor Hasret Demirci
Zahnarzt/-in
7 Jahre der Erfahrung
Türkei, Istanbul
NATURAL CLINIC

Doctor Hasret Demirci

Zahnarzt/-in
7 Jahre der Erfahrung
Dr. Hasret Demirci ist eine Zahnärztin, die sich auf operative Chirurgie mit akademischer Kompetenz spezialisiert hat.Mehr lesen
Dr. Hasret Demirci ist eine Zahnärztin, die sich auf operative Chirurgie mit akademischer Kompetenz spezialisiert hat.
Mehr lesen
Doctor Burak Demir
Zahnarzt/-in
11 Jahre der Erfahrung
Türkei, Istanbul
NATURAL CLINIC

Doctor Burak Demir

Zahnarzt/-in
11 Jahre der Erfahrung
Dr. Burak Demir ist Zahnarzt und begann seine berufliche Laufbahn im Jahr 2022. Er absolvierte seine Ausbildung an der Çukurova Universität, Abteilung für Zahnmedizin. Er hat an mehreren Kongressen und Workshops teilgenommen und ist Inhaber verschiedener Auszeichnungen und Mitgliedschaften.Mehr lesen
Dr. Burak Demir ist Zahnarzt und begann seine berufliche Laufbahn im Jahr 2022. Er absolvierte seine Ausbildung an der Çukurova Universität, Abteilung für Zahnmedizin. Er hat an mehreren Kongressen und Workshops teilgenommen und ist Inhaber verschiedener Auszeichnungen und Mitgliedschaften.
Mehr lesen
Gülyüz Öztürk
Pädiatrischer Hämatologe/-in / Onkologe/-in
32 Jahre der Erfahrung
4.1
7 Rezensionen

Gülyüz Öztürk

Pädiatrischer Hämatologe/-in / Onkologe/-in
32 Jahre der Erfahrung
Türkei, Istanbul
Acibadem Altunizade Hospital
4.1
7 Rezensionen
Arztbesuch preis auf anfrage
CAR-T-Zelltherapie $200000
Weitere Behandlungen
Ali Seydi Ozgul
Kardiologe/-in
16 Jahre der Erfahrung

Ali Seydi Ozgul

Kardiologe/-in
16 Jahre der Erfahrung
Türkei, Izmir
PARKHAYAT
Dharma Choudhary
Hämatologe/-in
20 Jahre der Erfahrung
4.5
32 Rezensionen
Indien, Delhi
BLK Super Speciality Hospital

Dharma Choudhary

Hämatologe/-in
20 Jahre der Erfahrung

Leiter der Abteilung Knochenmarktransplantation, Hämatologe

Mehr lesen

Leiter der Abteilung Knochenmarktransplantation, Hämatologe

4.5
32 Rezensionen
Arztbesuch preis auf anfrage
Allogene Knochenmarktransplantation von einem verwandten Spender $33000 - $37000
Chemotherapie $550
Knochenmarktransplantation $25000 - $90000
Weitere Behandlungen
Bernd Hertenstein
Klinischer Onkologe/-in
4.2
37 Rezensionen
Deutschland, Bremen
Krankenhaus Bremen Mitte (Bremen-Mitte Clinic)

Bernd Hertenstein

Klinischer Onkologe/-in
Dr. Bernd Hertenstein ist ein sehr erfahrener klinischer Onkologe, der sich auf Chemotherapie, Strahlentherapie, Stammzelltransplantation, Tumormarker-Bluttests und verschiedene andere Behandlungen für Krebspatienten spezialisiert hat. Außerdem ist er Autor zahlreicher Publikationen.Mehr lesen
Dr. Bernd Hertenstein ist ein sehr erfahrener klinischer Onkologe, der sich auf Chemotherapie, Strahlentherapie, Stammzelltransplantation, Tumormarker-Bluttests und verschiedene andere Behandlungen für Krebspatienten spezialisiert hat. Außerdem ist er Autor zahlreicher Publikationen.
Mehr lesen
Deenadayalan Munirathnam
Pädiatrischer Hämatologe/-in / Onkologe/-in
Indien, Mumbai
Global Hospital Mumbai

Deenadayalan Munirathnam

Pädiatrischer Hämatologe/-in / Onkologe/-in

Pädiatrischer Hämatologe-Onkologe, Spezialist für Knochenmarktransplantationen

Mehr lesen

Pädiatrischer Hämatologe-Onkologe, Spezialist für Knochenmarktransplantationen

Mehr lesen
Arztbesuch preis auf anfrage
Allogene Knochenmarktransplantation von einem nicht verwandten Spender $47000 - $119000
Knochenmarktransplantation
Allogene Knochenmarktransplantation von einem verwandten Spender $28000 - $34000
Weitere Behandlungen
Opdr Hasan
Gastroenterologe/-in
30 Jahre der Erfahrung

Opdr Hasan

Gastroenterologe/-in
30 Jahre der Erfahrung
Türkei, Istanbul
Forever Clinica
Adem Topaloglu
Chirurgischer Onkologe/-in
13 Jahre der Erfahrung

Adem Topaloglu

Chirurgischer Onkologe/-in
13 Jahre der Erfahrung
Türkei, Istanbul
ERDEM HOSPITAL
Woo Chul Moon
Klinischer Onkologe/-in
43 Jahre der Erfahrung

Woo Chul Moon

Klinischer Onkologe/-in
43 Jahre der Erfahrung
Republik Korea, Seoul
hilly pmc
Can Us
Schönheitschirurg/-in
6 Jahre der Erfahrung

Can Us

Schönheitschirurg/-in
6 Jahre der Erfahrung
Türkei, Istanbul
Esthetic Hospital
Gaurav Dixit
Hämatologe/Onkologe/-in
14 Jahre der Erfahrung
4.4
17 Rezensionen

Gaurav Dixit

Hämatologe/Onkologe/-in
14 Jahre der Erfahrung
Indien, Gurgaon
Artemis Hospitals
Assoc Prof Dr Halil Olgun
Neurochirurg/-in
16 Jahre der Erfahrung
4.4
14 Rezensionen

Assoc Prof Dr Halil Olgun

Neurochirurg/-in
16 Jahre der Erfahrung
Türkei, Istanbul
Hermes Clinics
Berfin Cakirgoz
Zahnarzt/-in
7 Jahre der Erfahrung

Berfin Cakirgoz

Zahnarzt/-in
7 Jahre der Erfahrung
Türkei, Istanbul
Integra Dental clinic
Mehdi Afrit
Hämatologe/Onkologe/-in
13 Jahre der Erfahrung
Vereinigte Arabische Emirate, Schardscha
Burjeel Specialty Hospital Sharjah

Mehdi Afrit

Hämatologe/Onkologe/-in
13 Jahre der Erfahrung

Biography

Dr. Mehdi Afrit is a Medical Oncologist who practices at Burjeel Specialty Hospital in Sharjah. He has over 11 years of experience caring for and managing cancer patients. He has extensive experience providing chemotherapy, hormonal therapy, immunotherapy, and targeted therapy to patients. He earned a Certificate of Medical Oncology from the Gustave Roussy Institute in Paris, France, where he received training in antitumor chemotherapy and cancer medical treatment. Additionally, he holds an international certificate in breast diseases. He also has a certificate in Good Clinical Practice from Trans Celerate Biopharma Inc. and a certificate in Clinical Trial Management: Good Clinical Practice from the Faculty of Pharmaceutical Medicine of the Royal College of Physicians. He previously worked for over five years as an Assistant Professor of Medical Oncology at Tunis’s Faculty of Medicine. He later practiced as a Consultant, Medical Oncologist for six years at Arianna’s hospital in Tunisia. He later worked for two years as a Specialist Medical Oncologist at Zulekha Hospital. He was also an investigator in three international clinical trials and holds clinical trial auditing and CRO certifications and a GCP Training Certificate from 2016. He is a member in good standing of the Emirates Oncology Society (EOS), the European Society of Medical Oncology (ESMO), and the American Society of Clinical Oncology (ASCO). His clinical expertise includes but is not limited to the following:

  • Oncology care and treatment for chemotherapy, hormonal therapy, immune therapy, and target therapy
  • Breast cancer
  • Solid tumor diagnosis
  • Digestive cancer
  • Gynecological cancer
  • Lung cancer
  • Genitourinary cancer
  • Sarcoma

Awards & Achievements

  • Award from Himaya Foundations and University of Sharjah

Research & Publications

  • Clinicopathological Features of Gastric Cancer in a Cohort of Gulf Council Countries' Patients: A Cross-Sectional Study of 96 Cases. Journal of Oncology Research Reviews & Reports Volume 2(2): 1-3.
  • The Burden of Gynecologic Cancers in the UAE. Journal of Oncology Research Reviews & Reports Volume 2(4): 1-6.
  • The Emirates Oncology Task Force Clinical Practice Guideline on Screening for SARS-CoV-2 in Asymptomatic Adult Cancer Patients Before Anti-Cancer Therapy. Journal of Oncology Research Reviews & Reports Volume 2(4): 1-6.
  • The State of Cancer Care in the United Arab Emirates in 2020: Challenges and Recommendations, A report by the United Arab Emirates Oncology Task Force. Humaid Al-Shamsi, Humaa Darr, Ibrahim Abu-Gheida , Jawaher Ansari, Martine, Mehdi Afrit, Mohamad H Masri, Mohamed Abuhaleeqa. Gulf J Oncology 2020 Jan;1(32):71-87.
  • Primary Bone Lymphoma: Tunisian Multicentric Retrospective Study About 32 Cases. Ben Ayed C, Laabidi S, Said N, Afrit M, Ben Ahmed S, Boussen H. Tunis Med. 2018 May;96(5):269-272.
  • First Site of Recurrence After Breast Cancer Adjuvant Treatment in the Era of Multimodality Therapy: Which Imaging for Which Patient During Follow-up? Nesrine M, Mehdi B, Houda EB, Soumaya L, Mehdi A, Bechir Z, Hamouda B. Breast Dis. 2017 Nov 21
Mehr lesen

Biography

Dr. Mehdi Afrit is a Medical Oncologist who practices at Burjeel Specialty Hospital in Sharjah. He has over 11 years of experience caring for and managing cancer patients. He has extensive experience providing chemotherapy, hormonal therapy, immunotherapy, and targeted therapy to patients. He earned a Certificate of Medical Oncology from the Gustave Roussy Institute in Paris, France, where he received training in antitumor chemotherapy and cancer medical treatment. Additionally, he holds an international certificate in breast diseases. He also has a certificate in Good Clinical Practice from Trans Celerate Biopharma Inc. and a certificate in Clinical Trial Management: Good Clinical Practice from the Faculty of Pharmaceutical Medicine of the Royal College of Physicians. He previously worked for over five years as an Assistant Professor of Medical Oncology at Tunis’s Faculty of Medicine. He later practiced as a Consultant, Medical Oncologist for six years at Arianna’s hospital in Tunisia. He later worked for two years as a Specialist Medical Oncologist at Zulekha Hospital. He was also an investigator in three international clinical trials and holds clinical trial auditing and CRO certifications and a GCP Training Certificate from 2016. He is a member in good standing of the Emirates Oncology Society (EOS), the European Society of Medical Oncology (ESMO), and the American Society of Clinical Oncology (ASCO). His clinical expertise includes but is not limited to the following:

  • Oncology care and treatment for chemotherapy, hormonal therapy, immune therapy, and target therapy
  • Breast cancer
  • Solid tumor diagnosis
  • Digestive cancer
  • Gynecological cancer
  • Lung cancer
  • Genitourinary cancer
  • Sarcoma

Awards & Achievements

  • Award from Himaya Foundations and University of Sharjah

Research & Publications

  • Clinicopathological Features of Gastric Cancer in a Cohort of Gulf Council Countries' Patients: A Cross-Sectional Study of 96 Cases. Journal of Oncology Research Reviews & Reports Volume 2(2): 1-3.
  • The Burden of Gynecologic Cancers in the UAE. Journal of Oncology Research Reviews & Reports Volume 2(4): 1-6.
  • The Emirates Oncology Task Force Clinical Practice Guideline on Screening for SARS-CoV-2 in Asymptomatic Adult Cancer Patients Before Anti-Cancer Therapy. Journal of Oncology Research Reviews & Reports Volume 2(4): 1-6.
  • The State of Cancer Care in the United Arab Emirates in 2020: Challenges and Recommendations, A report by the United Arab Emirates Oncology Task Force. Humaid Al-Shamsi, Humaa Darr, Ibrahim Abu-Gheida , Jawaher Ansari, Martine, Mehdi Afrit, Mohamad H Masri, Mohamed Abuhaleeqa. Gulf J Oncology 2020 Jan;1(32):71-87.
  • Primary Bone Lymphoma: Tunisian Multicentric Retrospective Study About 32 Cases. Ben Ayed C, Laabidi S, Said N, Afrit M, Ben Ahmed S, Boussen H. Tunis Med. 2018 May;96(5):269-272.
  • First Site of Recurrence After Breast Cancer Adjuvant Treatment in the Era of Multimodality Therapy: Which Imaging for Which Patient During Follow-up? Nesrine M, Mehdi B, Houda EB, Soumaya L, Mehdi A, Bechir Z, Hamouda B. Breast Dis. 2017 Nov 21
Mehr lesen
Assoc Prof Dr Ahmet Rauf
Thoraxchirurg/-in
32 Jahre der Erfahrung
4.4
14 Rezensionen

Assoc Prof Dr Ahmet Rauf

Thoraxchirurg/-in
32 Jahre der Erfahrung
Türkei, Istanbul
Hermes Clinics
Osman Ilhan
Hämatologe/-in
46 Jahre der Erfahrung
Türkei, Ankara
Private Koru Ankara Hospital

Osman Ilhan

Hämatologe/-in
46 Jahre der Erfahrung

Prof. Dr. Osman İLHAN graduated from Ankara University Faculty of Medicine in 1978. After completing his internal medicine residency at the same faculty in 1982, he served as a senior resident at the GATA Hematology Clinic during his military service. After completing his mandatory service at SSK Ulus Hospital, he returned to Ankara University Faculty of Medicine for a subspecialty. In 1990, he became an associate professor of hematology. He worked in Genoa, Italy to increase his knowledge and experience in leukemia. He was part of the team that performed the first bone marrow stem cell transplant in Turkey. In 1996, he went to the MD Anderson Cancer Center in the USA to work on "Stem Cell Mobilization, Cryopreservation, and Transplantation." In 1996, he became a professor of hematology. In 1999, he was elected as the regional president of ESFH (European Society for Hemapheresis). Dr. İlhan, who was the founder and president of the Hemapheresis Society in 2000, joined the World Apheresis Association (WAA) in 2001. He became the President of the Turkish Hematology Association in October 2001. Dr. İlhan, who is an active member of the European Hematology Association (EHA), was a member of the accreditation committee (ECAH) for education. He played a role in the accreditation of Turkish hematologists in CME credits by participating in the accreditation of congresses and courses held in Turkey as a Provider Status. He served as the founding president of the Cellular Therapy and Regenerative Medicine Association established in 2008. He became the founding president of the Geriatric Hematology Association in 2011. He is the Honorary President of the World Apheresis Congress (WAA) held in 2012. Dr. İlhan, who previously served on drug licensing and ethics committees at the Ministry of Health, has also served as the Chairman of the Photopheresis-Apheresis Commission and the Scientific Committee for Bone Marrow Transplantation, as well as the Chairman of the National Organ Tissue Cell Coordination Board, the Scientific Board of Cord Blood, and the Stem Cell Research Board. He is the founding president of the STEM CELL FOUNDATION and has played an important role in the establishment of TURKOK (Turkish Stem Cell Donor Bank). Dr. İlhan has over 300 publications in journals registered in PubMed and more than 5000 citations. He holds the Platinum CME certificate from the European Hematology Association. He owns four brands/patents named “Kökten Çözüm (Deep Solution), Telehematoloji (Telehematology), Hemaferez (Hemapheresis), Kanser Kök Hücresi (Cancer Stem Cell)”. He is currently the President of the Ankara Medical Association. Prof. Dr. Osman İlhan, who served at Ankara University Faculty of Medicine for 50 years, began working at Özel Koru Ankara Hospital as of January 1, 2023.

His medical interests include:

Hematopoietic Stem Cell Transplantation (Autologous, Allogeneic)

Acute Leukemia

Chronic Leukemia Treatments

Hodgkin Lymphoma

Non-Hodgkin Lymphoma Treatments

Multiple Myeloma Treatments, MDS

Aplastic Anemia

ITP

TTP Treatments

Hypercoagulability

Hereditary Thrombophilia Treatments

Therapeutic Apheresis

Photopheresis

Geriatric Hematology Diseases.

Mehr lesen

Prof. Dr. Osman İLHAN graduated from Ankara University Faculty of Medicine in 1978. After completing his internal medicine residency at the same faculty in 1982, he served as a senior resident at the GATA Hematology Clinic during his military service. After completing his mandatory service at SSK Ulus Hospital, he returned to Ankara University Faculty of Medicine for a subspecialty. In 1990, he became an associate professor of hematology. He worked in Genoa, Italy to increase his knowledge and experience in leukemia. He was part of the team that performed the first bone marrow stem cell transplant in Turkey. In 1996, he went to the MD Anderson Cancer Center in the USA to work on "Stem Cell Mobilization, Cryopreservation, and Transplantation." In 1996, he became a professor of hematology. In 1999, he was elected as the regional president of ESFH (European Society for Hemapheresis). Dr. İlhan, who was the founder and president of the Hemapheresis Society in 2000, joined the World Apheresis Association (WAA) in 2001. He became the President of the Turkish Hematology Association in October 2001. Dr. İlhan, who is an active member of the European Hematology Association (EHA), was a member of the accreditation committee (ECAH) for education. He played a role in the accreditation of Turkish hematologists in CME credits by participating in the accreditation of congresses and courses held in Turkey as a Provider Status. He served as the founding president of the Cellular Therapy and Regenerative Medicine Association established in 2008. He became the founding president of the Geriatric Hematology Association in 2011. He is the Honorary President of the World Apheresis Congress (WAA) held in 2012. Dr. İlhan, who previously served on drug licensing and ethics committees at the Ministry of Health, has also served as the Chairman of the Photopheresis-Apheresis Commission and the Scientific Committee for Bone Marrow Transplantation, as well as the Chairman of the National Organ Tissue Cell Coordination Board, the Scientific Board of Cord Blood, and the Stem Cell Research Board. He is the founding president of the STEM CELL FOUNDATION and has played an important role in the establishment of TURKOK (Turkish Stem Cell Donor Bank). Dr. İlhan has over 300 publications in journals registered in PubMed and more than 5000 citations. He holds the Platinum CME certificate from the European Hematology Association. He owns four brands/patents named “Kökten Çözüm (Deep Solution), Telehematoloji (Telehematology), Hemaferez (Hemapheresis), Kanser Kök Hücresi (Cancer Stem Cell)”. He is currently the President of the Ankara Medical Association. Prof. Dr. Osman İlhan, who served at Ankara University Faculty of Medicine for 50 years, began working at Özel Koru Ankara Hospital as of January 1, 2023.

His medical interests include:

Hematopoietic Stem Cell Transplantation (Autologous, Allogeneic)

Acute Leukemia

Chronic Leukemia Treatments

Hodgkin Lymphoma

Non-Hodgkin Lymphoma Treatments

Multiple Myeloma Treatments, MDS

Aplastic Anemia

ITP

TTP Treatments

Hypercoagulability

Hereditary Thrombophilia Treatments

Therapeutic Apheresis

Photopheresis

Geriatric Hematology Diseases.

Mehr lesen
Salih Dc
Gastroenterologe/-in
17 Jahre der Erfahrung

Salih Dc

Gastroenterologe/-in
17 Jahre der Erfahrung
Türkei, Istanbul
Esthetic Hospital